Setback for Genentech

October 1, 2005

Article

The FDA has denied Genentech's request to fast-track the application for its age-related macular degeneration (AMD) agent, Lucentis (ranibizumab). In response, Genentech announced it plans to file a complete Biologics License Application (BLA) for Lucentis for the treatment of neovascular AMD in December 2005, in a bid to speed up the process. Although the FDA rejected Genentech's request for fast-track designation, this should not affect the timing for BLA submission or the potential to obtain priority review.

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos

At the Retina World Congress, Siegfried Priglinger, MD, speaks about ensuring the best outcomes for preschool-aged patients

$At the 2025 ASCRS meeting, Robert Ang, MD said small aperture IOLs can benefit all patients, especially those with complex corneas or who have undergone previous corneal refractive surgery$

Viha Vig, MBChB graduate student at the University of Auckland, New Zealand, discusses her poster presentation on the relationship between mitochondiral disease, Alzheimer disease, and other types of dementia.

Alfredo Sadun, MD, PhD, chief of Ophthalmology at the Doheny Eye Institute, University of California Los Angeles, shared exciting new research with the Eye Care Network during the Association for Research in Vision and Ophthalmology (ARVO) meeting on the subject of Leber hereditary optic neuropathy (LHON).

At this year's Association for Research in Vision and Ophthalmology (ARVO) meeting in Salt Lake City, Utah, Nitish Mehta, MD, shared highlights from his research documenting real-world results of aflibercept 8 mg for patients with diabetic macular oedema.

ARVO 2025: Anat Loewenstein, MD, shares data from herself and her colleagues on meeting needs of patients with diabetic retinopathy

$At the American Society of Cataract and Refractive Surgeons annual meeting, Sheng Lim, MD, FRCOphth discusses the benefit of endoscopic cyclophotocoagulation for patients with primary open angle glaucoma and cataracts in the CONCEPT study$

Anat Loewenstein, MD, Professor and Director, Department of Ophthalmology, Tel Aviv Medical Center, discusses the Congress on Controversies in Ophthalmology (COPHy)

Anat Loewenstein, MD, speaks about the 22nd Annual Angiogenesis, Exudation, and Degeneration Meeting in February 2025 and shares her global forecast for AI-driven home OCT

Related Content

A man undergoes evaluation in an ophthalmologist's office for uveitis. Concept image for uveitis research United Kingdom England Europe posterior and anterior eye ocular infection. Image credit: ©Maria Vitkovska – stock.adobe.com

Early uveitis detection and intervention is key to vision preservation, systemic health

New clinical guidance for anterior and posterior uveitis was published by a research team from the University of Bristol

Higher molar dose and its translation into clinical practice. Led by John Kitchens, MD; Joined by Peter Kaiser, MD

Higher Molar Dose and Its Translation into Clinical Practice

John Kitchens, MD;Peter Kaiser, MD

Prof Alió is a member of the Ophthalmology Times Europe Editorial Advisory Board. Here, he holds the certificate of his International Research Excellence Award. Image courtesy of Prof Jorge Alió

Jorge Alió, MD, PhD, FEBOphth, FWCRS, receives 2024 International Research Excellence Award

Prof Alió was commended for his work in microincisional cataract surgery and accommodative IOLs for presbyopia

A single-shot, 130-degree OCTA image of the retina captured using DREAM OCT. Image courtesy of Intalight

EMA issues CE mark for DREAM OCT (Intalight)

The OCT platform offers deep imaging depth, rapid sweeping speed, extensive scan range, accurate results and multimodal imaging capabilities

A woman with glasses helps a child, who may be her daughter, use a tablet. Concept image for online school, homeschool, screen time, myopia, and paediatric astigmatism. Image credit: ©K2L Family – stock.adobe.com

Research links COVID-19 to prevalence and severity of paediatric astigmatism

The study found an increase in both refractive astigmatism and corneal astigmatism among a patient population of schoolchildren

A pharmacist helps a customer access medication. Concept image for neovascular age-related macular degeneration eye drop treatment therapy. Image credit: ©Gorodenkoff – stock.adobe.com

Topline results from investigational nAMD drop SYL1801 (Sylentis)

Three dose level cohorts of the small interfering RNA therapeutic were evaluated in a double-blind study

Related Content

A man undergoes evaluation in an ophthalmologist's office for uveitis. Concept image for uveitis research United Kingdom England Europe posterior and anterior eye ocular infection. Image credit: ©Maria Vitkovska – stock.adobe.com

Early uveitis detection and intervention is key to vision preservation, systemic health

New clinical guidance for anterior and posterior uveitis was published by a research team from the University of Bristol

Higher molar dose and its translation into clinical practice. Led by John Kitchens, MD; Joined by Peter Kaiser, MD

Higher Molar Dose and Its Translation into Clinical Practice

John Kitchens, MD;Peter Kaiser, MD

Prof Alió is a member of the Ophthalmology Times Europe Editorial Advisory Board. Here, he holds the certificate of his International Research Excellence Award. Image courtesy of Prof Jorge Alió

Jorge Alió, MD, PhD, FEBOphth, FWCRS, receives 2024 International Research Excellence Award

Prof Alió was commended for his work in microincisional cataract surgery and accommodative IOLs for presbyopia

A single-shot, 130-degree OCTA image of the retina captured using DREAM OCT. Image courtesy of Intalight

EMA issues CE mark for DREAM OCT (Intalight)

The OCT platform offers deep imaging depth, rapid sweeping speed, extensive scan range, accurate results and multimodal imaging capabilities

A woman with glasses helps a child, who may be her daughter, use a tablet. Concept image for online school, homeschool, screen time, myopia, and paediatric astigmatism. Image credit: ©K2L Family – stock.adobe.com

Research links COVID-19 to prevalence and severity of paediatric astigmatism

The study found an increase in both refractive astigmatism and corneal astigmatism among a patient population of schoolchildren

A pharmacist helps a customer access medication. Concept image for neovascular age-related macular degeneration eye drop treatment therapy. Image credit: ©Gorodenkoff – stock.adobe.com

Topline results from investigational nAMD drop SYL1801 (Sylentis)

Three dose level cohorts of the small interfering RNA therapeutic were evaluated in a double-blind study

Editorial Board

Terms and Conditions

Do Not Sell My Personal Information

Contact Info

2 Commerce Drive
Cranbury, NJ 08512

© 2025 MJH Life Sciences

All rights reserved.